Terms ending in 2028
Every in-force patent on Pfizer Inc.'s record whose computed term ends in 2028, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,877,761 | Novel N-pyrimidin-4-yl-3-amino-pyrrolo[3,4-c]pyrazole Derivatives as PKC Kinase Inhibitors Grace period ended Nov 4, 2026 · lapse expected · Low confidence | Pfizer Inc. | Grace period ended Nov 4, 2026 lapse expected | Low confidence | |
| US 9,518,060 | SUBSTITUTED PYRROLO[3,4-c]PYRAZOLES AS PKC KINASE INHIBITORS In force · Medium confidence | Pfizer Inc. | In force | Medium confidence | |
| US 10,316,045 | SUBSTITUTED PYRROLO[3,4-c]PYRAZOLES AS PKC KINASE INHIBITORS In force · Medium confidence | Pfizer Inc. | In force | Medium confidence | |
| US 11,220,518 | SUBSTITUTED N-PYRIMIDIN-4-YL-3-Amino-PYRROLO[3,4-c]PYRAZOLES AS PROTEIN KINASE C INHIBITORS In force · Medium confidence | Pfizer Inc. | In force | Medium confidence | |
| US 11,780,853 | SUBSTITUTED N-PYRIMIDIN-4-YL-3-Aminopyrrolo[3,4-c]PYRAZOLES AS PROTEIN KINASE C INHIBITORS In force · Medium confidence | Pfizer Inc. | In force | Medium confidence | |
| US 8,721,601 | Dose Setting Mechanism for an Injection Device In force · High confidence | Pfizer Inc. | In force | High confidence | |
| US 7,632,854 | Aminoindazole Derivatives Active as Kinase Inhibitors, Process for Their Preparation and Pharmaceutical Compositions Comprising Them In force · High confidence | Nerviano Medical Sciences S.R.L | In force | High confidence | |
| US 8,247,411 | Sulfonyl Amide Derivatives for the Treatment of Abnormal Cell Growth In force · High confidence | Pfizer Inc. | In force | High confidence | |
| US 8,440,822 | Sulfonyl Amide Derivatives for the Treatment of Abnormal Cell Growth In force · Medium confidence | Pfizer, Inc. | In force | Medium confidence | |
| US 10,450,297 | Sulfonyl Amide Derivatives for the Treatment of Abnormal Cell Growth In force · Low confidence | Pfizer, Inc. | In force | Low confidence | |
| 8 more term ends in 2028 · Pro | |||||
10 of 18 patents shown. Soonest term end first, then patent number.
Pro members see all 18, including 10 expiring within the 18 months from Nov 16, 2026.
10 of these are in force and held by Pfizer Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.